Literature DB >> 11388054

[Development of the incidence and mortality of breast cancer].

N Becker1.   

Abstract

In Germany, breast cancer is still the most frequent cancer site with approximately 45.000 incident cases and 18.000 deaths annually. After a continuous increase of mortality for decades and a short period of stagnation, a decline can be observed since a couple of years. However, this turnaround has not been preceded by an analogous evolution of breast cancer incidence. A similar development can also be observed in other countries. The conditions under which this changing trend has occurred indicate that it might have been caused mainly by better treatment and only to a low extent by altered prevalence of risk factors or the implementation of screening programmes. Due to the expected latency, an influence of organized screening on mortality can be expected only at the end of the 1990s, i.e., at the end of the period for which data is available or later. In the discussion about implementation of quality-controlled screening in Germany, it should be kept in mind that the quality of the entire programme--starting with screening and ending with therapy--will decide to what extent breast cancer mortality can be reduced.

Entities:  

Mesh:

Year:  2001        PMID: 11388054     DOI: 10.1007/s001170051011

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  4 in total

1.  Breast Cancer and Socioeconomic Status in Austria.

Authors:  Ursula Kunze; Gabriela Böhm
Journal:  Breast Care (Basel)       Date:  2009-08-20       Impact factor: 2.860

2.  Report on trends of incidence (1970-2002) of and mortality (1952-2002) from cancer in Germany.

Authors:  Nikolaus Becker; Hans-Peter Altenburg; Christa Stegmaier; Hartwig Ziegler
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-03       Impact factor: 4.553

3.  [Breast cancer metastases in the head and neck region].

Authors:  P J Schuler; S Heikaus; U Friebe-Hoffmann; T K Hoffmann; J Greve; T Klenzner; J Schipper; K Scheckenbach
Journal:  HNO       Date:  2010-08       Impact factor: 1.284

4.  Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.

Authors:  Christian Schindlbeck; Udo Jeschke; Sandra Schulze; Uwe Karsten; Wolfgang Janni; Brigitte Rack; Harald Sommer; Klaus Friese
Journal:  Histochem Cell Biol       Date:  2005-05-12       Impact factor: 4.304

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.